Identification of occult tumor cells in node negative lymph nodes of colorectal cancer patients by cytokeratin 20 gene and protein expression
✍ Scribed by S. Lassmann; M. Bauer; R. Rosenberg; H. Nekarda; R. Soong; R. Rüger; H. Höfler; M. Werner
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 320 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0179-1958
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The aim of our prospective study was to detect circulating epithelial cells (CEC) indicating the presence of disseminated tumor cells (DTC) in tissues affected by lymphatic and hematogenic colorectal cancer metastasis. DTC were tracked in lymph node, liver or bone marrow samples of 245 colorectal ca
## Abstract The purpose of our study was to develop specific, sensitive, objective assays for early detection of disseminated tumour cells in patients with colorectal cancer (CRC). Carcinoembryonic antigen (CEA) and cytokeratin 20 (CK20) were chosen as markers because they are selectively expressed
## Background and objectives: Lymph node metastasis is known as a significant predictor of prognosis in colorectal cancer patients. recently, reverse transcriptase polymerase chain reaction (rt-pcr) has been applied to detecting micrometastasis. to assess the risk of recurrence and accurately deter
Background. The aim of this study was to investigate the value of p53 and cyclin D1 gene expression in predicting the risk of occult lymph node metastases in patients with head and neck squamous cell carcinoma (HNSCC). Methods. The expression of cyclin D1 and p53 was evaluated by means of immunohis
## Abstract Conventional histopathologic staging of primary colorectal cancers does not allow accurate prognostic stratification within a given tumour stage. Therefore, PCR‐based assays are increasingly used to try to predict more accurately the likelihood of disease progression for the individual